The FY2025 (Dec) proxy of Tango Therapeutics names 18 peer companies for pay. Among Tango Therapeutics and these peers, CEO pay was 7th highest of 8.
7th highest of 8in Tango Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
$2.5M$9.5M
Pay peer group, FY2025 (Dec) proxy
| IDEAYA Biosciences | ||
| Kymera Therapeutics | ||
| Celldex Therapeutics | ||
| Cullinan Therapeutics | ||
| Kura Oncology | ||
| Relay Therapeutics | ||
| Keros Therapeutics | ||
| Bicycle Therapeutics plc | Not disclosed | Not disclosed |
| CARGO Therapeutics, Inc. | Not disclosed | Not disclosed |
| Dyne Therapeutics | Not disclosed | Not disclosed |
| Foghorn Therapeutics, Inc. | Not disclosed | Not disclosed |
| Merus N.V. | Not disclosed | Not disclosed |
| Pliant Therapeutics, Inc. | Not disclosed | Not disclosed |
| Repare Therapeutics, Inc. | Not disclosed | Not disclosed |
| Replimune Group, Inc. | Not disclosed | Not disclosed |
| Syndax Pharmaceuticals | Not disclosed | Not disclosed |
| Zentalis Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| iTeos Therapeutics, Inc. | Not disclosed | Not disclosed |
18 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.